Us Bancorp \De\ Grifols Sa Transaction History
Us Bancorp \De\
- $77.3 Billion
- Q3 2024
A detailed history of Us Bancorp \De\ transactions in Grifols Sa stock. As of the latest transaction made, Us Bancorp \De\ holds 20,663 shares of GRFS stock, worth $140,921. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,663
Previous 18,407
12.26%
Holding current value
$140,921
Previous $115,000
59.13%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding GRFS
# of Institutions
165Shares Held
140MCall Options Held
268KPut Options Held
389K-
Capital World Investors Los Angeles, CA21MShares$143 Million0.03% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA19.9MShares$136 Million2.11% of portfolio
-
Permian Investment Partners, LP New York, NY12.3MShares$84.1 Million16.06% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.1MShares$75.8 Million3.5% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny10.7MShares$73.2 Million0.05% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $4.63B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...